Cytodyn Inc (CYDY)

[CTMedic]

Closet investor,

I’m glad we can agree.

Again, advanced discussions for meeting of failing primary endpoints is not the role of the FDA. CYDY are either met or they failed the primary endpoint, the FDA doesn’t need to clarify that.

Cytodyn and fda are meeting. Without need for FDA to clarify endpoints and advance discussions of failing primary endpoints, I will return to their meeting to discuss approval of leronlimab based on good results and the path forward.

Let’s check back in two weeks.